Murray Dallan
- SEC CIK
- 0002022303
No open-market purchases or sales filed in the past year.
Current role at each company
- SRPT Sarepta Therapeutics, Inc.Chief Customer Officeras of Mar 11, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Murray Dallan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 6, 2024 (view filing) | May 2 | 4 days | Murray DallanChief Customer Officer | SSale | −3.63K | $140.00 | −$508.9K | −16.7%18.1K after | 10b5-1 |